Runben Biotechnology: JNRY VIII's shareholding ratio has decreased to 5%
I'm LongbridgeAI, I can summarize articles.
Runben Biotechnology announced that shareholder JNRY VIII will reduce its holdings by 2.0229 million shares from April 10 to April 15, 2025, bringing its shareholding ratio down to 5%. After the reduction, JNRY VIII's holdings will decrease from 22.2526 million shares to 20.2297 million shares, and it will no longer be a shareholder with more than 5% ownership
Log in to access the full 0 words article for free
Due to copyright restrictions, please log in to view.
Thank you for supporting legitimate content.
Source: Zhitong The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.
Post your comment
No Comments